Abstract 7301: FP011, A tri-specific immune checkpoint inhibitor targeting PD-1 × TIGIT × PVRIG for cancer immunotherapy
Sign Up to like & getrecommendations! Published in 2025 at "Cancer Research"
DOI: 10.1158/1538-7445.am2025-7301
Abstract: Immune checkpoint inhibitors, such as anti-PD-1/PD-L1 antibodies, have rapidly changed the treatment paradigm for multiple tumor types. Unfortunately, many patients still remain unresponsive or acquire resistance after initial response to treatment. The complex network of… read more here.
Keywords: cancer; fp011; pvrig; tumor ... See more keywords